TEPH Insta 20/40

TEPH Insta 20/40 Capsules / Sachet

(Omeprazole + Sodium Bicarbonate)

DESCRIPTION:

TEPH Insta is a mix of omeprazole, a proton-siphon inhibitor, and sodium bicarbonate, an acid neutralizer. Omeprazole is a subbed benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl sulfinyl)- 1H-benzimidazole, a racemic combination of two enantiomers that hinders gastric corrosive emission. Its exact equation is C17H19N3O3S, with a sub-atomic load of 345.42.

PHARMACOLOGY:

Instrument of Activity: Omeprazole has a place with a class of antisecretory compounds, the subbed benzimidazoles, that don’t show anticholinergic or H2 receptor opposing properties, however that stifle gastric corrosive emission by specific inhibition of the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell .Since this protein framework is viewed as the corrosive (proton) siphon inside the gastric mucosa, omeprazole has been portrayed as a gastric corrosive siphon inhibitor, in that it hinders the last step of corrosive creation. This impact is portion related and prompts restraint of both basal and animated corrosive discharge regardless of the improvement. Omeprazole is corrosive labile and along these lines quickly corrupted by gastric corrosive. Omeprazole/sodium bicarbonate capsules and sachet are immediate-release formulations that contain sodium bicarbonate which raises the gastric pH and thus protects omeprazole from acid degradation

 

PHARMACOKINETICS:

Absorption:

Also for the When omeprazole/sodium bicarbonate capsules and sachet are administered on an empty stomach 1 hour prior to a meal, the absorption of omeprazole is rapid When omeprazole/sodium bicarbonate capsules and sachet are administered 1 hour after a meal, the omeprazole AUC is reduced by approximately 24% relative to administration 1 hour prior to a meal

Distribution:

Omeprazole is bound to plasma proteins. Protein binding is approximately 95%

Metabolism:

Also for the Following single-dose oral administration of omeprazole, the majority of the dose (about 77%) is eliminated in urine as at least six metabolites. Two metabolites have been distinguished as hydroxyomeprazole and the relating carboxylic corrosive. The rest of the portion was recoverable in excrement. This suggests a critical biliary discharge of the metabolites of omeprazole. Three metabolites have been distinguished in plasma-the sulfide and sulfone subsidiaries of omeprazole, and hydroxyomeprazole. These metabolites have very little or no antisecretory movement

Excretion:

Following single-portion oral organization of omeprazole, little if any, unaltered medication is discharged in pee

The mean plasma omeprazole half-life in solid subjects is roughly 60 minutes (Reach: 0.4 to 3.2 hours)

INDICATIONS:

Most patients heal within four weeks. A few patients might require four extra long stretches of treatment

Gastric Ulcer:

Omeprazole/sodium bicarbonate capsules and sachet are indicated for short-term treatment (4-8 weeks) of aclive benign gastric ulcer GI Bleeding in critically ill patients: Omeprazole/sodium bicarbonate capsules and sachet are indicated for decrease treatment of chance of upper gastrointestinal

bleeding in critically ill patients Treatment of Gastroesophageal Reflux Disease (GERD)

DOSAGE AND ADMINISTRATION:

Also for the sachet into 1 to 2 tablespoonfuls (15 to 30ml) of water. Stir well and drink immediately. Refill cup with water and drink. Do not use other liquids or contents of Pour the foods

DIRECTION FOR USE (Sachet):

SIDE EFFECTS:

Body as a Whole:

Hypersensitivity

reactions, including anaphylaxis, anaphylactic shock, angioedema, bronchospasm, interstitial nephritis, urticaria, fever, pain, fatigue and malaise Cardiovascular: Chest pain or angina, tachycardia, bradycardia, palpitation, elevated blood pressure, and peripheral edema

Gastrointestinal:

Pancreatitis (sometimes fatal), anorexia, imitable colon, flatulerice, fecal discoloration, esophageal candidiasis, mucosal atrophy of the tongue, dry mouth, stomatitis

Hepatic:

Rarely overt liver disease has occurred, including hepatocellular, cholestatic, or mixed hepatitis, liver necrosis (sometimes fatal), hepatio  fallure (sometimes

fatal), and hepatic encephalopathy Metabolic/

Nutritional:

Hyponatremia, hypoglycemia, and weight gain

Musculoskeletal:

Muscle cramps, myalgia, muscle shortcoming, joint agony, bone break, and leg torment

Nervous System/Psychiatric:
Mystic aggravations including discouragement, disturbance, hostility, fantasies, disarray, a sleeping disorder, apprehension, quakes, disregard, lethargy, nervousness, dream irregularities, dizziness, paresthesia, and hemifacial dysesthesia

Respiratory:

Epistaxis, pharyngeal pain

Skin:

Rash and rarely, cases of severe generalized skin reactions including toxic epidermal necrolysis, purpura and/or petechite (sometimes with rechallenge); skin

inflammation, urticaria, angioedema, pruritus, photosensitivity, alopecia, dry skin, and hyperhidrosis Special Senses: Tinnitus, taste perversion

Ocular:

Blurred vision, ocular imtation, dry eye syndrome, optic atrophy, anterior ischemic optic neuropathy, optic neurills and double vision Urogenital: Interstitial nephritis (sometimes with positive rechallenge), urinary recurrence, raised serum creatinine,proteinuria, hemaluna, glycosuria, testicular agony, and gynecomastia

DRUG INTERACTIONS:

There have been reports of expanded INR and prothrombin time in patients getting proton siphon inhibitors, including omeprazole, and warfarin correspondingly

WARNINGS AND PRECAUTIONS:

 

 

* Gastric Malignancy:

  • In adults, symptomatic response does not preclude the presence of gastric malignancy Corisider additional follow-up and diagnostic testing

Pregnancy:

 

 

 

Pregnancy Category C:

There are no sufficient and very much controlled examinations in pregnant ladies. The plasma half-life averaged one hour, about the same as that in nonelderly, healthy subjects taking omeprazole and sodium bicarbonate.

OVERDOSE:

In the event of overdosage, treatment should be symptomatic & supportive

CONTRAINDICATIONS:

 

SHELF LIFE:

See expiry on the pack

AVAILABILITY:

TEPH in 20 capsules in a pack of 14’s

Tipi Insta 40 capsules in a pack of 14’s

20 sachet in a pack of 10’s

TEPH Insta 40 sachet in a pack of 10’s

 

 

 

 

INSTRUCTIONS:

Keep out of reach of children

Avoid exposure to heal, light and humidity

Store between 15 to 30°C

Improper storage may deteriorate the medicine

Manufactured by:

SAMI Pharmaceuticals (Pvt.) Ltd. F-95, SITE, Karachi-Pakistan.

ٹیف انشا ۴۰۱۲۰ کپسول | ساشے

(اولی پر از دل هوایم پائی کار یونیت)

خوراک ڈاکٹر کی ہدایت کے مطابق استعمال کریں

طریق استعمال: ساشے کے پاؤڈر کو اسے آ کھانے کے پیچھے ( ۱۵ سے ۳۰ ملی لیٹر ) پانی میں حل

کریں اور فورا استعمال کر لیں

کپ میں دوبارہ پانی بھریں اور پی لیں

پانی کے علاوہ کسی اور شے کے ساتھ استعمال نہ کریں

ہدایات: بچوں کی پہنچ سے دور رکھیں

دوا کو دھوپ ، گرمی اور نجی سے محفوظ ۱۵ سے ۳۰ ڈگری سینٹی گریڈہ

کے درمیان میں رکھیں ورنہ دو اخراب ہو جائیگی

Leave a Comment